Clinical Trials Update: July 3, 2007
Tuesday, July 3, 2007; 12:00 AM
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Vascular Diseases
 
Eleven soccer-playing teens from the D.C.-area spent two weeks in Africa. See the team in action on the field -- and off.  
Read their first-person experiences with HIV/AIDS and poverty.  
Hear what each player had to say both before and after heading to South Africa.  
Your Co-Workers Like McSteamy?
We can help you find the right work environment with competitive benefits. Nursing, Allied Health: Get a New Job
|
This study will evaluate the effectiveness and safety of treatment with Sutent in people with unresectable or metastatic vascular sarcoma. Patients may be eligible if treated previously with one or two chemotherapy regimens, bevacizumab, or tyrosine kinase inhibitors. Candidates must be 18 or older and have a histopathologically-proven diagnosis of angiosarcoma, epithelioid sarcoma-like hemangioendothelioma, or Kaposis sarcoma. Additional criteria apply.
The research site is in New York City.
More information
Please see http:/
-----
Smoking Cessation
This seven-week outpatient study will evaluate an investigational medication to help people quit smoking. Participants must be ages 12 to 16, smoke at least three cigarettes a day, be physically healthy, and weigh at least 66 pounds.
The research site is in Houston, Texas.
More information
Please see http:/
